No Data
No Data
Tango Therapeutics(TNGX.US) Insider Sells US$985.88K in Common Stock
$Tango Therapeutics(TNGX.US)$ Insider MVA Investors, LLC sold 140K shares of common stock on Jun 6, 7, 2024 at an average price of $7.04 for a total value of $985.88K. This transaction involves other
Tango Therapeutics(TNGX.US) Director Sells US$36,039 in Common Stock
$Tango Therapeutics(TNGX.US)$ Director Calhoun Lesley Ann sold 5,000 shares of common stock on Jun 5, 2024 at an average price of $7.2078 for a total value of $36,039.Source: Announcement What is stat
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
PDF Version BOSTON--(BUSINESS WIRE)--Jun. 5, 2024-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), Tango Therapeutics (TNGX)
Express News | Tango Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $13 From $16
No Data